The chemical substance with the name "(3S,4R)-4-[4-[4-(Dimethoxymethyl)-1-piperidinyl]-3-fluorophenyl]-3,4-dihydro-3-phenyl-2H-1-benzopyran-7-ol" and CAS number "2504914-79-6" is a complex organic compound characterized by its multi-cyclic structure, which includes a benzopyran moiety. This compound features stereocenters, indicated by the (3S,4R) configuration, which contributes to its potential biological activity and interaction with biological targets. The presence of a dimethoxymethyl group and a piperidine ring suggests that it may exhibit properties relevant to medicinal chemistry, possibly acting as a pharmacophore in drug development. Additionally, the fluorophenyl group may enhance lipophilicity and influence the compound's pharmacokinetics. The hydroxyl group at the 7-position of the benzopyran structure may also play a role in its reactivity and solubility. Overall, this compound's unique structural features may confer specific biological activities, making it a candidate for further research in therapeutic applications.

(3S,4R)-4-[4-[4-(Dimethoxymethyl)-1-piperidinyl]-3-fluorophenyl]-3,4-dihydro-3-phenyl-2H-1-benzopyran-7-ol

2504914-79-6: The chemical substance with the name "(3S,4R)-4-[4-[4-(Dimethoxymethyl)-1-piperidinyl]-3-fluorophenyl]-3,4-dihydro-3-phenyl-2H-1-benzopyran-7-ol" and CAS number "2504914-79-6" is a complex organic compound characterized by its multi-cyclic structure, which includes a benzopyran moiety. This compound features stereocenters, indicated by the (3S,4R) configuration, which contributes to its potential biological activity and interaction with biological targets. The presence of a dimethoxymethyl group and a piperidine ring suggests that it may exhibit properties relevant to medicinal chemistry, possibly acting as a pharmacophore in drug development. Additionally, the fluorophenyl group may enhance lipophilicity and influence the compound's pharmacokinetics. The hydroxyl group at the 7-position of the benzopyran structure may also play a role in its reactivity and solubility. Overall, this compound's unique structural features may confer specific biological activities, making it a candidate for further research in therapeutic applications.

<p>ER ligand-6 serves as the target protein ligand for the PROTAC ER Degrader-14.</p>

CAS 2504914-79-6

(3S,4R)-4-[4-[4-(Dimethoxymethyl)-1-piperidinyl]-3-fluorophenyl]-3,4-dihydro-3-phenyl-2H-1-benzopyran-7-ol

ER ligand-6

Ref: TM-T204548